Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

859 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The European Multiple System Atrophy-Study Group (EMSA-SG).
Geser F, Seppi K, Stampfer-Kountchev M, Köllensperger M, Diem A, Ndayisaba JP, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Dodel R, Klockgether T, Ghorayeb I, Yekhlef F, Tison F, Daniels C, Kopper F, Deuschl G, Coelho M, Ferreira J, Rosa MM, Sampaio C, Bozi M, Schrag A, Hooker J, Kim H, Scaravilli T, Mathias CJ, Fowler C, Wood N, Quinn N, Widner H, Nilsson CF, Lindvall O, Schimke N, Eggert KM, Oertel W, del Sorbo F, Carella F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Meco G, Colosimo C, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Ory F, Rascol O, Kamm C, Buerk K, Maass S, Gasser T, Poewe W, Wenning GK; EMSA-SG. Geser F, et al. Among authors: oertel w. J Neural Transm (Vienna). 2005 Dec;112(12):1677-86. doi: 10.1007/s00702-005-0328-y. Epub 2005 Jul 29. J Neural Transm (Vienna). 2005. PMID: 16049636 Review.
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
Rascol O, Brooks DJ, Melamed E, Oertel W, Poewe W, Stocchi F, Tolosa E; LARGO study group. Rascol O, et al. Among authors: oertel w. Lancet. 2005 Mar 12-18;365(9463):947-54. doi: 10.1016/S0140-6736(05)71083-7. Lancet. 2005. PMID: 15766996 Clinical Trial.
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.
Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P, Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio C; European Federation of Neurological Societies; Movement Disorder Society-European Section. Horstink M, et al. Among authors: oertel w. Eur J Neurol. 2006 Nov;13(11):1170-85. doi: 10.1111/j.1468-1331.2006.01547.x. Eur J Neurol. 2006. PMID: 17038031 Review.
Multiple system atrophy.
Oertel WH, Bandmann O. Oertel WH, et al. J Neural Transm Suppl. 1999;56:155-64. doi: 10.1007/978-3-7091-6360-3_9. J Neural Transm Suppl. 1999. PMID: 10370909 Review.
Clinical risk-benefit assessment of dopamine agonists.
Möller JC, Eggert KM, Unger M, Odin P, Chaudhuri KR, Oertel WH. Möller JC, et al. Among authors: oertel wh. Eur J Neurol. 2008 Sep;15 Suppl 2:15-23. doi: 10.1111/j.1468-1331.2008.02214.x. Eur J Neurol. 2008. PMID: 18702738 Review.
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.
Ferreira JJ, Katzenschlager R, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, Rascol O, Sampaio C, Schüpbach M, Tolosa E, Trenkwalder C, Schapira A, Berardelli A, Oertel WH. Ferreira JJ, et al. Among authors: oertel wh. Eur J Neurol. 2013 Jan;20(1):5-15. doi: 10.1111/j.1468-1331.2012.03866.x. Eur J Neurol. 2013. PMID: 23279439 Review.
859 results